These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 8570211

  • 1. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta.
    Riese DJ, Bermingham Y, van Raaij TM, Buckley S, Plowman GD, Stern DF.
    Oncogene; 1996 Jan 18; 12(2):345-53. PubMed ID: 8570211
    [Abstract] [Full Text] [Related]

  • 2. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R, Lenferink AE, Bacus SS, Lyass L, van de Poll ML, Klapper LN, Tzahar E, Sela M, van Zoelen EJ, Yarden Y.
    Oncogene; 1998 Mar 12; 16(10):1249-58. PubMed ID: 9546426
    [Abstract] [Full Text] [Related]

  • 3. Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression.
    Sundaresan S, Roberts PE, King KL, Sliwkowski MX, Mather JP.
    Endocrinology; 1998 Dec 12; 139(12):4756-64. PubMed ID: 9832411
    [Abstract] [Full Text] [Related]

  • 4. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH.
    EMBO J; 1997 Sep 15; 16(18):5608-17. PubMed ID: 9312020
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB, Hynes NE, Lane HA.
    Cancer Res; 2002 Jun 01; 62(11):3151-8. PubMed ID: 12036928
    [Abstract] [Full Text] [Related]

  • 6. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.
    Graus-Porta D, Beerli RR, Daly JM, Hynes NE.
    EMBO J; 1997 Apr 01; 16(7):1647-55. PubMed ID: 9130710
    [Abstract] [Full Text] [Related]

  • 7. Studies on the betacellulin receptor in pancreatic AR42J cells.
    Ishiyama N, Kanzaki M, Seno M, Yamada H, Kobayashi I, Kojima I.
    Diabetologia; 1998 Jun 01; 41(6):623-8. PubMed ID: 9662041
    [Abstract] [Full Text] [Related]

  • 8. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase.
    Harari D, Tzahar E, Romano J, Shelly M, Pierce JH, Andrews GC, Yarden Y.
    Oncogene; 1999 Apr 29; 18(17):2681-9. PubMed ID: 10348342
    [Abstract] [Full Text] [Related]

  • 9. ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture.
    Huotari MA, Miettinen PJ, Palgi J, Koivisto T, Ustinov J, Harari D, Yarden Y, Otonkoski T.
    Endocrinology; 2002 Nov 29; 143(11):4437-46. PubMed ID: 12399441
    [Abstract] [Full Text] [Related]

  • 10. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells.
    Uchida T, Wada K, Akamatsu T, Yonezawa M, Noguchi H, Mizoguchi A, Kasuga M, Sakamoto C.
    Biochem Biophys Res Commun; 1999 Dec 20; 266(2):593-602. PubMed ID: 10600548
    [Abstract] [Full Text] [Related]

  • 11. Ligands for ErbB-family receptors encoded by a neuregulin-like gene.
    Chang H, Riese DJ, Gilbert W, Stern DF, McMahan UJ.
    Nature; 1997 May 29; 387(6632):509-12. PubMed ID: 9168114
    [Abstract] [Full Text] [Related]

  • 12. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
    Riese DJ, Kim ED, Elenius K, Buckley S, Klagsbrun M, Plowman GD, Stern DF.
    J Biol Chem; 1996 Aug 16; 271(33):20047-52. PubMed ID: 8702723
    [Abstract] [Full Text] [Related]

  • 13. Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer.
    Srinivasan R, Benton E, McCormick F, Thomas H, Gullick WJ.
    Clin Cancer Res; 1999 Oct 16; 5(10):2877-83. PubMed ID: 10537356
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG, Dilts CA, Dziubinski ML, Pierce LJ, Ethier SP.
    Mol Carcinog; 1996 Mar 16; 15(3):227-38. PubMed ID: 8597535
    [Abstract] [Full Text] [Related]

  • 15. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.
    Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L, Lavi S, Seger R, Ratzkin BJ, Sela M, Yarden Y.
    EMBO J; 1996 May 15; 15(10):2452-67. PubMed ID: 8665853
    [Abstract] [Full Text] [Related]

  • 16. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases.
    Carraway KL, Weber JL, Unger MJ, Ledesma J, Yu N, Gassmann M, Lai C.
    Nature; 1997 May 29; 387(6632):512-6. PubMed ID: 9168115
    [Abstract] [Full Text] [Related]

  • 17. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.
    Komurasaki T, Toyoda H, Uchida D, Morimoto S.
    Oncogene; 1997 Dec 04; 15(23):2841-8. PubMed ID: 9419975
    [Abstract] [Full Text] [Related]

  • 18. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG, Hosick HL, Ethier SP.
    J Cell Physiol; 2000 Jun 04; 183(3):301-13. PubMed ID: 10797304
    [Abstract] [Full Text] [Related]

  • 19. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
    Piepkorn M, Predd H, Underwood R, Cook P.
    Arch Dermatol Res; 2003 Jul 04; 295(3):93-101. PubMed ID: 12768307
    [Abstract] [Full Text] [Related]

  • 20. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells.
    Ram TG, Kokeny KE, Dilts CA, Ethier SP.
    J Cell Physiol; 1995 Jun 04; 163(3):589-96. PubMed ID: 7775601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.